Man Group PLC Inovio Pharmaceuticals, Inc. Transaction History

Man Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.38 - $0.58 $13,512 - $20,624	35,560 Added 59.87%	94,956 $37,000
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $23,164 - $55,832	59,396 New	59,396 $26,000
Q1 2021 May 17, 2021	SELL	$8.81 - $16.96 $7.03 Million - $13.5 Million	-797,994 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $4.38 Million - $6.62 Million	515,546 Added 182.53%	797,994 $7.06 Million
Q3 2020 Nov 16, 2020	SELL	$9.57 - $27.05 $1.02 Million - $2.88 Million	-106,645 Reduced 27.41%	282,448 $3.28 Million
Q2 2020 Aug 14, 2020	BUY	$7.14 - $31.69 $2.78 Million - $12.3 Million	389,093 New	389,093 $10.5 Million
Q3 2018 Nov 14, 2018	SELL	$3.92 - $5.58 $662,480 - $943,020	-169,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$4.05 - $5.69 $684,450 - $961,610	169,000 New	169,000 $796,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.